Categories

Sign Up to Receive the Latest Trading Tips and News from Prosper



    March 1, 2019

    European Regulators Give A Helping Hand To Lexicon Pharmaceuticals

    Lexicon Pharmaceuticals (LXRX) rallied strongly today after the European Medicines Agency’s Committee for Medicinal Product for Human Use gave LXRX’s Zynquista a positive mention. Zynquista is a joint development between Lexicon and Sanofi. Zynquista’s application for approval in the United States and Europe has been accepted and is currently under review. Here’s a recap.

    Read Article
    February 28, 2019

    Let’s Dive Into Biotech With Mike Patton

    Here’s a sneak peek of one of the industry’s most reputable, hands-on trading programs with Mike Patton. Grab a free day pass to one of our live signal trading rooms today>>http://bit.ly/fb-free-pass  

    Read Article
    February 28, 2019

    Aceto Corporation Treading Water

    Aceto Corporation (ACET) shares are down today after rising yesterday. The company filed for chapter 11 bankruptcy on February 20th, causing the stock to plunge over 65%. The bounce appeared to be merely technical in nature, as trading data overwhelming shows net selling over today’s session. The company plans to make some adjustments in order […]

    Read Article
    February 26, 2019

    The Clock Is Ticking On Karyopharm Therapeutics

    Karyopharm Therapeutics Inc (KPTI) shares were down today as the company awaits the FDA’s decision on its Selinexor new drug application (“NDA”). The company’s stock dropped sharply on Friday, losing around 50% of its value due to FDA notes being leaked, in which the FDA voiced skepticism as to the benefit of approving the new […]

    Read Article
    February 25, 2019

    Be Mike Patton’s Co-Pilot

    Here’s a sneak peek of one of the industry’s most reputable, hands-on trading programs with Mike Patton. Grab a free day pass to one of our live signal trading rooms today>>http://bit.ly/fb-free-pass  

    Read Article
    February 25, 2019

    Zosano On the Launching Pad Again

    Zosano Pharma Corp (ZSAN) shares were up over 23% today following news last week that the company reached its final milestone in its long-term safety study of Qtrypta for the acute treatment of migraine disease. The stock is still well below the 6.65 high price from February 21st, but we can now expect the stock […]

    Read Article
    February 22, 2019

    Darker Days Ahead For Karyopharm Therapeutics?

    Karyopharm Therapeutics (KPTI) shares were down sharply today after negative comments from the FDA regarding their drug application for Selinexor. The FDA noted that it doesn’t see the benefit of the drug with respect to its potential risks. This report was to be released later this month, but apparently was leaked today, causing the sharp […]

    Read Article
    February 21, 2019

    No More Headaches For Zosana Pharma?

    Zosano Pharma Corp (ZSAN) shares rose dramatically today due to the news that the company met the final milestones for its long-term safety study of Qtrypta, an acute treatment for migraine disease. The stock moved up over +180% on extremely high volume, with very little hesitation along the way. Here’s a recap.

    Read Article
    February 19, 2019

    Block Chain Is Back!

    RIOT Blockchain (RIOT) shares rose sharply today due to bullish trading in the cryptocurrency markets. RIOT made a name for itself (quite literally) in 2017 when it decided to abandon its previous business activities in the healthcare space and convert itself into a cryptocurrency mining operation. This decision essentially saved the company from sinking due […]

    Read Article
    February 15, 2019

    Have A Seat With Mike Patton

    Here’s a sneak peek of one of the industry’s most reputable, hands-on trading programs with Mike Patton. Grab a free day pass to one of our live signal trading rooms today>>http://bit.ly/fb-free-pass  

    Read Article